Cancer cells exploit the “immune checkpoint” function to evade the immune system (134) by expression of programmed cell death-1 (PD-1) or anti–cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) resulting in increased apoptosis of T cells. Here, CTLA4 is linked to cancer.